Future of clinical development highlighted in online event

Outsourcing Pharma

Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances. Clinical Development

Nimbus Therapeutics Strengthens Clinical Development Leadership Team

BioTech 365

Nimbus Therapeutics Strengthens Clinical Development Leadership Team Nimbus Therapeutics Strengthens Clinical Development Leadership Team CAMBRIDGE, Mass.–(BUSINESS

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ukraine war dramatically impacting global clinical development: Phesi

Outsourcing Pharma

The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders. Clinical Development

Navigating the challenges of proper fill and finish in clinical development

Bio Pharma Dive

Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance

CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations

BioTech 365

CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations BEIJING & CAMBRIDGE, Mass.–(BUSINESS

Biophytis provides updates on Sarconeos (BIO101) clinical development

BioTech 365

Biophytis / Key word(s): Miscellaneous Biophytis provides updates on Sarconeos (BIO101) clinical development 07-Apr-2022 / 08:00 CET/CEST Biophytis provides updates on Sarconeos (BIO101)clinical development Sarcopenia (SARA) : discussions engaged with FDA for the preparation of a Phase 2-3 program … Continue reading → EQS Newsfeed

Samsung Biologics to help Enzolytics advance clinical development of mAbs

BioPharma Reporter

Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing

Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT

BioTech 365

Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT – New next-gen SPEAR … Continue reading → GlobeNewswire

Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease

BioTech 365

Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease – Single pivotal trial to initiate later this month targets the broad patient population … Continue reading → Business Wire

Adverum Down After Clinical Development Shift for Gene Therapy Program

BioSpace

Shares of Adverum Biotechnologies plunged more than 20% in premarket trading after the company announced it was revising its clinical development plan for investigational gene therapy candidate ADVM-022 based on safety concerns in patients with diabetic macular edema (DME

Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan

BioTech 365

Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan U.S. FDA clears IND to evaluate MET642 for the treatment of ulcerative colitis Sufficient capital to complete Phase 2 IBD … Continue reading → GlobeNewswire

Brii Biosciences Provides Update on Strategic Clinical Development Progress

BioTech 365

Brii Biosciences Provides Update on Strategic Clinical Development Progress Brii Biosciences Provides Update on Strategic Clinical Development Progress Company received U.S.

Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development

BioTech 365

Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development Successful IPO on Euronext Growth® in Paris Cash … Continue reading → Business Wire

2022 Oncolytic Virotherapies Analytical Tool: A Must Have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer – ResearchAndMarkets.com

BioTech 365

2022 Oncolytic Virotherapies Analytical Tool: A Must Have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer – ResearchAndMarkets.com 2022 Oncolytic Virotherapies Analytical Tool: A Must Have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer – ResearchAndMarkets.com … Continue reading → Business Wire

Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease

BioTech 365

Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease CTA approved by Health Canada in November 2021; … Continue reading → Business Wire

AlgoTherapeutix Receives Regulatory Approval to Initiate Clinical Development of ATX01

BioTech 365

Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates

BioTech 365

Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates Announced positive topline data from EQUATE … Continue reading → Business Wire

Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates

BioTech 365

Novavax Announces COVID-19 Vaccine Clinical Development Progress

The Pharma Data

Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. Novavax completed enrollment of 15,000 participants in a pivotal Phase 3 clinical trial being conducted in the U.K.

Immune-Onc Therapeutics Announces the Selection of Clinical Development Candidate IO-106, a First-in-Class Myeloid and Stromal Checkpoint Inhibitor Targeting LAIR1

BioTech 365

Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines

BioTech 365

Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines — Curevo’s lead program is CRV-101, … Continue reading → Business Wire

Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership

BioTech 365

Bayer Starts Phase III Clinical Development Program OASIS With Investigational Product, Elinzanetant

BioTech 365

CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV

BioTech 365

CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV – Phase 1 dose-escalation study started at clinical … Continue reading → EQS NewsfeedDGAP-News: CureVac / Key word(s): Study 30.03.2022 / 13:00 The issuer is solely responsible for the content of this announcement.

Reata Pharmaceuticals, Inc. to Report First Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on May 10, 2022

BioTech 365

to Report First Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on May 10, 2022 Reata Pharmaceuticals, Inc. to Report First Quarter 2022 Financial Results and to Provide an Update on Clinical … Continue reading → Business Wire

ITM and Helmholtz Munich Sign Cooperation Agreement for the Clinical Development of Radiopharmaceutical Therapy to Treat Glioblastoma Multiforme

BioTech 365

ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments

BioTech 365

ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments EVANSTON, Ill.–(BUSINESS

Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update

BioTech 365

Prokarium Appoints Uz Stammberger as Chief Medical Officer to Drive Clinical Development in Oncology

BioTech 365

The Case for Early Regulatory Consideration for Clinical Development of Chimeric Antigen Receptor T cell (CART)

CATO Research

Hence, the next clinical milestone will very likely be the development of allogeneic CART therapies that could offer off-the-shelf products with immediate availability as an on-demand therapeutic option for patients with high unmet medical needs. Meeting Clinical Objectives.

Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development

BioTech 365

Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Key leadership appointment of Dr. Morriss enhances the company’s research … Continue reading → Business Wire

SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience

BioTech 365

SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience Bernard Coulie, M.D.,

AlgoTherapeutix Receives Regulatory Approval to Initiate Clinical Development of ATX01

The Pharma Data

AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01. Their lead programme ATX01 is in clinical development in Chemotherapy-Induced Peripheral Neuropathy. 15, 2020 07:15 UTC.

Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19 Antiviral CDI-45205

BioTech 365

Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19 Antiviral CDI-45205 Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19 Antiviral CDI-45205 Response to pre-IND briefing package supports pathway to initiating a Phase 1 … Continue reading → GlobeNewswire

Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE

BioTech 365

Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE – Company plans to focus development of Zygel™ in FXS, ASD and 22q – – Company … Continue reading → GlobeNewswire

Clinical trial evolution, innovation center of Oracle Health Sciences event

Outsourcing Pharma

Clinical DevelopmentThe two-day Oracle Health Sciences Connect will gather an array of research experts to discuss how to make the most of emerging technologies and practices.

Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights

BioTech 365

Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights On Track to Initiate … Continue reading → Business Wire

Modra Pharmaceuticals Appoints Two New Supervisory Board Members Adding Significant Experience in Corporate and Clinical Development

BioTech 365

Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development

BioTech 365

Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development Press Release Nicox Appoints Doug Hubatsch as new Chief Scientific … Continue reading → GlobeNewswire

Komodo Health Announces Agreement to Accelerate Clinical Development with Real-World Patient Data and Software

BioTech 365